1. Long‐term safety and sustained efficacy of extended‐release pramipexole in early and advanced Parkinson's disease. (4th February 2014) Authors: Hauser, R. A.; Schapira, A. H. V.; Barone, P.; Mizuno, Y.; Rascol, O.; Busse, M.; Debieuvre, C.; Fraessdorf, M.; Poewe, W. Journal: European journal of neurology Issue: Volume 21:Number 5(2014:May) Page Start: 736 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Patient‐reported convenience of once‐daily versus three‐times‐daily dosing during long‐term studies of pramipexole in early and advanced Parkinson's disease. Issue 1 (27th April 2012) Authors: Schapira, A. H. V.; Barone, P.; Hauser, R. A.; Mizuno, Y.; Rascol, O.; Busse, M.; Debieuvre, C.; Fraessdorf, M.; Poewe, W. Journal: European journal of neurology Issue: Volume 20:Issue 1(2013:Jan.) Page Start: 50 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Success rate, efficacy, and safety/tolerability of overnight switching from immediate‐ to extended‐release pramipexole in advanced Parkinson's disease. Issue 1 (31st July 2012) Authors: Schapira, A. H. V.; Barone, P.; Hauser, R. A.; Mizuno, Y.; Rascol, O.; Busse, M.; Debieuvre, C.; Fraessdorf, M.; Poewe, W. Journal: European journal of neurology Issue: Volume 20:Issue 1(2013:Jan.) Page Start: 180 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗